Company: PED
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001654954-25-013092
Chunk: 279

Company: PEDEVCO CORP
Filing Date: 2025-11-14
Form: 10-Q
Item: Part II, Item 4
Chunk 279
---
 “November Form 8-K”), which is incorporated by reference herein. Mr. Long also subscribed to purchase shares of the Series A Convertible Preferred Stock of the Company in the Company’s recent October 2025 PIPE financing, pursuant to his entry into a subscription agreement with the Company, also discussed in greater detail in the November Form 8-K. There are no arrangements or understandings between Messrs. Pinkston and Long and any other person pursuant to which Messrs. Pinkston and Long were selected to serve as an officer of the Company, nor are Messrs. Pinkston and Long a participant in any related party transaction required to be reported pursuant to Item 404(a) of Regulation S-K, except as to Mr. Pinkston, those that are described under, or incorporated by reference in, “Certain Relationships and Related Party Transactions” in the Proxy Statement and as to Mr. Long, in connection with his participation in the PIPE financing, as discussed in the November Form 8-K. There are no family relationships between any director or executive officer of the Company, including Messrs. Pinkston and Long.

Biographical information for Messrs. Pinkston (age 57) and Long (age 49), is provided in the Proxy Statement under “Executive Officers-—Paul A. Pinkston, Chief Accounting Officer” and in the November Form 8-K under “Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers—Appointment of New Executive Officers”, respectively, which information and disclosures are incorporated by reference herein.

(c) Rule 10b5-1 Trading Plans. 

Our directors and executive officers may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. During the quarter ended September 30, 2025, none of the Company’s directors or officers (as defined in Rule 16a-1(f)) adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement”.

 44Table of Contents

ITEM 6. EXHIBITS

 Incorporated By ReferenceNo